RxDoctor Payments Data

Benjamin Weyer, PA

Physician Assistant · Jasper, INNPI 1962053579

Payments from drug & device makers

$586in general payments, 2019–2025

Across 24 payments — averaging $24.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$166
  • AstraZeneca$114
  • Edwards Lifesciences$71
  • Boston Scientific$53
  • Amgen$51
  • Biotronik Inc.$35
  • plus $96 from 5 others

What the payments were for

  • Food & beverage$47281%
  • Education$11419%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$586 in reported general payments places this provider in the 65th percentile of 1,955 physician assistant providers in Indiana.

See all physician assistant providers in Indiana

Medicare billing

Part B allowed, 2024
$90,860
Medicare patients
507
Services billed
1,514

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban310$268,738
EntrestoSacubitril/Valsartan87$83,459
XareltoRivaroxaban76$76,549
JardianceEmpagliflozin56$36,252
FarxigaDapagliflozin Propanediol33$21,796
Repatha PushtronexEvolocumab11$6,429
Metoprolol Succinate312$4,575
Bumetanide104$2,973
Midodrine Hcl45$2,432
Potassium Chloride97$1,822
Diltiazem 24hr Er (Cd)Diltiazem Hcl85$1,646
Ranolazine ErRanolazine16$1,299
Amlodipine Besylate212$1,173
Atorvastatin Calcium186$1,161
Isosorbide Mononitrate ErIsosorbide Mononitrate127$1,112

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$166$83,45987 claims
Boehringer IngelheimJardiance$26$36,25256 claims
AstraZenecaFarxiga$114$21,79633 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,955 physician assistant providers in Indiana.

Other physician assistant in Jasper

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →